Significant benefit of high-dose furmonertinib in the treatment of leptomeningeal metastases from non-small-cell lung cancer with EGFR ex19Del mutation: Two case reports and a literature review

Huan Han(Zhengzhou University), Hong Tang(First Affiliated Hospital of Jiangxi Medical College), Jiuzhou Zhao(University of Akron), xiao Zhang(Xi'an Medical University), Xiao Liu(Chinese Academy of Sciences), Hui Zhu(Sun Yat-sen University), Jianwei Zhang(Zhengzhou University), Shuyue Jiao(Henan Cancer Hospital)
Research Square
November 21, 2023
Cited by 0


Related Papers